Abstract |
Successful achievement of RNA interference in therapeutic applications requires safe and efficient vectors for siRNA delivery. In the present study, we demonstrate that a triethanolamine ( TEA)-core PAMAM dendrimer of generation 5 (G(5)) is able to deliver sticky siRNAs bearing complementary A(n)/T(n) 3'-overhangs effectively to a prostate cancer model in vitro and in vivo and produce potent gene silencing of the heat shock protein 27, leading to a notable anticancer effect. The complementary A(n)/T(n) (n = 5 or 7) overhangs characteristic of these sticky siRNA molecules help the siRNA molecules self-assemble into "gene-like" longer double-stranded RNAs thus endowing a low generation dendrimer such as G(5) with greater delivery capacity. In addition, the A(n)/T(n) (n = 5 or 7) overhangs act as protruding molecular arms that allow the siRNA molecule to enwrap the dendrimer and promote a better interaction and stronger binding, ultimately contributing toward the improved delivery activity of G(5). Consequently, the low generation dendrimer G(5) in combination with sticky siRNA therapeutics may constitute a promising gene silencing-based approach for combating castration-resistant prostate tumors or other cancers and diseases, for which no effective treatment currently exists.
|
Authors | Xiaoxuan Liu, Cheng Liu, Erik Laurini, Paola Posocco, Sabrina Pricl, Fanqi Qu, Palma Rocchi, Ling Peng |
Journal | Molecular pharmaceutics
(Mol Pharm)
Vol. 9
Issue 3
Pg. 470-81
(Mar 05 2012)
ISSN: 1543-8392 [Electronic] United States |
PMID | 22208617
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Dendrimers
- Ethanolamines
- PAMAM Starburst
- RNA, Small Interfering
- triethanolamine
|
Topics |
- Animals
- Apoptosis
(genetics, physiology)
- Blotting, Western
- Cell Line, Tumor
- Dendrimers
(administration & dosage, chemistry)
- Ethanolamines
(chemistry)
- Flow Cytometry
- Gene Silencing
(physiology)
- Humans
- Immunohistochemistry
- Male
- Mice
- Mice, Nude
- Microscopy, Confocal
- Prostatic Neoplasms
(genetics, therapy)
- RNA, Small Interfering
(administration & dosage, genetics)
- Real-Time Polymerase Chain Reaction
- Xenograft Model Antitumor Assays
|